Clinical Trial Update: 18F ML-10 for Early Detection of Response of Brain Metastases to WBRT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the imaging agent 18F ML-10 for early detection of response of brain metastases to whole-brain radiotherapy has been complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• [18F]-ML-10 (Fluorine-18 ML-10)

Snippet

Sponsor: Aposense Ltd. | Conditions: Solid Tumors, Brain Metastases | Phase 2 | Status: COMPLETED